Basal cell carcinoma (BCC) is a common skin cancer originating from basal cells in the epidermis. It is primarily caused by prolonged exposure to ultraviolet (UV) radiation. Clinically significant due to its potential for local invasion and destruction of surrounding tissues, BCC rarely metastasizes. Accurate coding with ICD-10 Code C44.619 facilitates precise diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and resource allocation.
ICD-10 Code C44.619 specifically denotes basal cell carcinoma located on the skin of the left upper limb, including the shoulder. This code is utilized when documenting cases of BCC that are localized to this anatomical region, ensuring accurate representation of the patient's condition for clinical documentation and billing purposes.
Basal cell carcinoma is primarily caused by UV radiation exposure, leading to mutations in skin cells. It typically presents as a pearly or waxy bump and can progress locally if untreated, necessitating medical intervention. Early detection and treatment are crucial to prevent complications.
ICD-10 Code C44.619 is integral in SOAP notes for documenting the patient's symptoms, assessment findings, and treatment plans. It is relevant in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.
In SOAP notes, ICD-10 Code C44.619 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of basal cell carcinoma. This linkage is essential for continuity of care, supporting billing processes, and meeting EHR documentation standards.
Timely treatment of basal cell carcinoma is crucial to prevent local invasion and complications. Surgical excision is the primary treatment modality.
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C44.619 is essential for accurate billing in hospital, ER, or outpatient settings.
CPT Code | Description |
---|---|
11400 | Excision, benign skin lesion, face, ears, scalp, neck; excised diameter up to 4.0 cm. |
11600 | Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter up to 1.0 cm. |
99213 | Established patient office visit, low to moderate complexity. |
Common Questions About Using ICD-10 Code C44.619 for Basal cell carcinoma skin/ left upper limb, inc shoulder
What are the common symptoms of basal cell carcinoma?
Common symptoms include a pearly or waxy bump, ulceration, and bleeding at the site. Patients may also report itching or tenderness.
How is basal cell carcinoma treated?
Treatment typically involves surgical excision of the tumor. Mohs micrographic surgery may be used for high-risk cases to ensure complete removal.
Is basal cell carcinoma contagious?
No, basal cell carcinoma is not contagious. It is primarily caused by UV exposure and is not transmitted between individuals.
How often should patients with basal cell carcinoma be monitored?
Patients should have regular follow-ups, typically every 6 to 12 months, to monitor for recurrence or new lesions.
Clinical Notes
SOAP notes
DAP notes
AI medical notes